Nevertheless, all the FLT4 mutations (missense or small in-frame deletions) known to cause Milroy disease have been located in 2 intracellular kinase domains (exons 17–26) and are assumed to interfere with the tyrosine kinase activation of the VEGFR3 receptor [15, 58]. The gene discussed is FLT4; the disease is Milroy disease.